 |
Articles: Drug Approvals |
Prior Articles
U.s. food and drug administration approves onglyza (saxagliptin) for the treatment of type 2 diabetes mellitus in adults
AstraZeneca, 08/04/09
Free full text
Avastin approved in US for the most common type of kidney cancer
Roche, 08/04/09
Free full text
U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
Bristol Myers-Squibb Company, 08/04/09
Free full text
FDA Approves Avastin for the Most Common Type of Kidney Cancer
Genentech, 08/04/09
Free full text
FDA Approves INVEGA SUSTENNA for the Acute and Maintenance Treatment of Schizophrenia
Janssen, 08/03/09
Free full text
INVEGA Approved as the First and Only Treatment for Schizoaffective Disorder
Janssen, 08/03/09
Free full text
U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
Bristol Myers-Squibb Company, 08/03/09
Free full text
FDA Approves Expanded Use of ISENTRESS (raltegravir) in Combination Therapy for Adult Patients with HIV-1 Infection to Include Patients Not Previously Treated with HIV Medicines
Merck & Co., 08/03/09
Free full text
AstraZeneca submits New Drug Applications for ZACTIMA in second-line advanced non-small cell lung cancer
AstraZeneca, 07/31/09
Free full text
Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
BioMarin, 07/31/09
Free full text
European commission approves broader label for Avastin allowing combination with docetaxel for the first-line treatment of advanced (metastatic) breast cancer
Roche, 07/30/09
Free full text
Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
Warner Chilcott, 07/30/09 Taro Receives FDA Approval for Cetirizine Hydrochloride Tablets (OTC) ANDA
Taro Pharmaceuticals USA, 07/29/09
Free full text
Generic omeprazole delayed-release capsules: in vitro performance evaluations
Drug Development and Industrial Pharmacy, 07/27/09 Ilaris recommended for European approval as new biologic drug to treat a rare but serious group of auto-inflammatory diseases
Novartis, 07/27/09
Free full text
Synthon Receives Final Approval for Bicalutamide 50mg
Synthon, 07/24/09
Free full text
FDA Panel Recommends Approval of Medtronic Heart Valve Under Humanitarian Device Exemption
Medtronic, 07/23/09
Free full text
FDA approves Tekturna HCT as initial treatment in patients unlikely to achieve their blood pressure goal with a single agent
Novartis, 07/22/09
Free full text
Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
Mylan, 07/21/09 Unimed pharmaceuticals, llc, decides not to file a patent infringement suit at this time against perrigo israel pharmaceuticals, ltd. following the receipt of a paragraph iv certification for a generic formulation of androgel 1%
Solvay, 07/20/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
